Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 97 (RPL21P97)

Target
RPL21P97
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 97 (RPL21P97) is classified as a processed pseudogene in the human genome[1][4][5][11]. Pseudogenes are DNA sequences similar to functional genes but typically lack the ability to encode functional proteins due to mutations or loss of regulatory elements[5][6]. RPL21P97 is derived from the ancestral ribosomal protein L21 gene, but, unlike the protein-coding RPL21 gene, it does not produce a functional ribosomal protein and is not implicated in any known biological processes, pathways, or diseases. There are no known drugs or therapies that interact with, or act through, this pseudogene. Key distinctions: - The protein-coding RPL21 gene (not RPL21P97) encodes a component of the 60S ribosomal subunit and is associated with protein synthesis and some genetic diseases, but pseudogenes like RPL21P97 do not share these characteristics[7][10][13]. - RPL21P97 is not a therapeutic target, gene product, or biomarker candidate, and is included in genetic databases mainly for genome annotation purposes[5][11]. This entry is specific and accurate based on available genetic and biological data.

Other names
RPL21_40_1120RPL21P97[1][4][11]

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 97 (RPL21P97).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 97 (RPL21P97).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call